TRIALS IN MAN WITH LIVE RECOMBINANTS MADE FROM A/PR/8/34 (H0 N1) AND WILD H3 N2 INFLUENZA VIRUSES
- 1 October 1975
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 306 (7938) , 729-732
- https://doi.org/10.1016/s0140-6736(75)90720-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Induction of Partial Immunity to Influenza by a Neuraminidase-specific VaccineThe Journal of Infectious Diseases, 1974
- Nonlinkage of Neurovirulence Exclusively to Viral Hemagglutinin or Neuraminidase in Genetic Recombinants of A/NWS (H0N1) Influenza VirusJournal of Virology, 1973
- Temperature-Sensitive Mutants of Influenza Virus. II. Attenuation of ts Recombinants for ManThe Journal of Infectious Diseases, 1972
- Association of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in ManNew England Journal of Medicine, 1972
- Segregation of Antigenic and Biological Characteristics during Influenza Virus RecombinationJournal of General Virology, 1972
- RECOMBINANT INFLUENZA-A VIRUSES AS LIVE VACCINES FOR MAN: Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus VaccinesThe Lancet, 1971
- Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccinesEpidemiology and Infection, 1971
- Investigation into the Attenuation of Influenza Viruses by Serial PassageBMJ, 1968
- Recombination of Influenza A Viruses of Human and Animal OriginScience, 1968
- An Improved Assay for the Infectivity of Influenza VirusesEpidemiology and Infection, 1958